About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,994 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,994 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4201-4220 of 7,994 trials

TerminatedPacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)The goal of the study is to find the best dose of pacritinib when given in combination with erlotinib.NCT02342353·St Louis, Missouri CompletedOmitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid SizeMany studies suggested that selective lymph node sampling was acceptable for specific non-small cell lung cancer (NSCLC).NCT06516796·Nanjing, Jiangsu CompletedMaintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerFor elderly patient, the treatment of Non Small Cell Lung Cancer was based on monotherapy but IFCT-0501 trial begun in 2006, demonstrated that a bitherapy (carboplatin and…NCT01850303·Abbeville and 77 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingMultiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung CancerLung cancer is one of the diseases with the highest global incidence and mortality.NCT07057102·Beijing, Beijing Municipality

Active not recruitingA Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursThis clinical trial is evaluating a drug called HMBD-001 (an anti-HER3 monoclonal antibody) in participants with advanced HER3 positive solid tumours.NCT05057013·London and 3 others

CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung CancerDrugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00021060·Boston, Massachusetts

RecruitingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsPhase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with…NCT06814496·Gilbert, Arizona and 2 others

Not yet recruitingA Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerThis is a trial to evaluate the efficacy, safety, and tolerability of HS-10370 in combination with Platinum-based Doublet Chemotherapy With or Without Adebrelimab Versus…NCT07822542

UnknownLiquid Biopsy in Advanced Oligometastatic NSCLC Receiving SurgeryA prospective, observational study that assesses the clinical feasibility of ctDNA-based liquid biopsy in patients with oligometastatic NSCLC receiving surgery.NCT05648370·Guangzhou, Guangdong

Not yet recruitingGut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic CancersThis study aims to investigate the role of the gut microbiota and its derived factors, including bacterial-associated antigens that mimic tumor-associated antigens, in predicting…NCT07815873·Milan, MI

CompletedSubcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung CancerThe goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic…NCT07099105·Seoul

CompletedThoracoscopy in Patients With Stage IIIA Non-Small Cell Lung CancerRATIONALE: Diagnostic procedures such as thoracoscopy may help to measure a patient's response to previous treatment.NCT00003566·Anniston, Alabama and 71 others

CompletedA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyThe goal of the first part of this clinical research study is to learn how to deliver more accurate radiation treatment of tumors in the spine.NCT01624220·Houston, Texas

RecruitingNeoadjuvant Immunotherapy for Stage III Non-small Cell Lung CancerThis is a phase II, non-randomized, open-label, multi-center study to evaluate the efficacy of neoadjuvant Sintilimab (PD-1 antibody) or combined with chemotherapy as first-line…NCT04728724·Shanghai

RecruitingA Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid TumorsThis study is an open-label, multicenter, dose-escalation and cohort-expansion, non-randomized Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic…NCT07056556·Shanghai, Shanghai Municipality

CompletedChemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003089·Philadelphia, Pennsylvania

CompletedErlotinib and Sunitinib in NSCLC* To determine the safety and maximally tolerated dose of sunitinib plus erlotinib in patients with non-small cell lung cancer (NSCLC).NCT00581789·Madison, Wisconsin

TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesThis phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain…NCT04789668·Houston, Texas

CompletedCediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Cediranib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00795340·Rio de Janeiro and 18 others

RecruitingWhole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CTActivity of patritumab deruxtecan (U3-1402; HER3-DXd) has been shown in a phase I/II study in patients with HER3 expressing breast cancer as well as in a phase I study in patients…NCT06222489·Amsterdam, North Holland

PreviousPage 211 of 400Next